These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The action of neuroleptics on different types of catalepsy in rats with a genetic predisposition to catatonic reactions]. Kolpakov VG; Nikulina EM; Alekhina TA; Gevorgian MM Zh Vyssh Nerv Deiat Im I P Pavlova; 1995; 45(2):388-94. PubMed ID: 7597835 [TBL] [Abstract][Full Text] [Related]
3. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton]. Gábor M Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764 [No Abstract] [Full Text] [Related]
4. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases]. ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836 [No Abstract] [Full Text] [Related]
5. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs. Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865 [TBL] [Abstract][Full Text] [Related]
6. Effect of venoruton on hypoxic stress-induced neurotoxicity in mice and oxygen free radical generation by human neutrophils. Shukla VK; Sethi AK; Garg SK; Ganguly NK; Kulkarni SK Arch Int Pharmacodyn Ther; 1989; 299():127-33. PubMed ID: 2774763 [TBL] [Abstract][Full Text] [Related]
7. Venoruton as a radioprotector: a haematological assessment. Kanwar KC; Shukla VK; Verma A Radiobiol Radiother (Berl); 1990; 31(6):517-22. PubMed ID: 2101456 [TBL] [Abstract][Full Text] [Related]
8. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow. Dobbins DE; Soika CY; Dabney JM Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155 [TBL] [Abstract][Full Text] [Related]
9. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs]. Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372 [No Abstract] [Full Text] [Related]
10. Influence of 0-(beta-hydroxyethyl)-rutin on the oedema-inhibiting effect of indomethacin. Blazsó G; Gábor M Acta Pharm Hung; 1994 Jul; 64(4):123-4. PubMed ID: 7976365 [TBL] [Abstract][Full Text] [Related]
11. Effect of Venoruton on the factor XIII activity in rat plasma. Grochal M; Sempińska-Edelberg E; Plewiński J Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007 [TBL] [Abstract][Full Text] [Related]
12. GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats. Shukla VK; Garg SK; Mathur VS; Kulkarni SK Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):236-48. PubMed ID: 3938209 [TBL] [Abstract][Full Text] [Related]
13. Anticatatonic effect of clonidine: its interaction with dopaminergic, anticholinergic and GABA-ergic drugs. Shukla VK; Garg SK; Kulkarni SK Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):33-43. PubMed ID: 3021074 [TBL] [Abstract][Full Text] [Related]
14. Venoruton in the therapy of central retinal vein occlusion. Zygulska-Mach H; Kostka-Trabka E; Kielar J; Grodzinska L; Dieron K; Kedzior A Ther Hung; 1985; 33(2):79-82. PubMed ID: 3842005 [No Abstract] [Full Text] [Related]
15. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study]. Artaria LG Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553 [No Abstract] [Full Text] [Related]
16. Protective effects of O-(beta-hydroxyethyl)-rutosides (HR) against adriamycin-induced toxicity in rats. Gulati OP; Nordmann H; Aellig A; Maignan MF; McGinness J Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):323-34. PubMed ID: 4004421 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements. Belcaro G; Rulo A; Candiani C Vasa; 1989; 18(2):146-51. PubMed ID: 2662674 [TBL] [Abstract][Full Text] [Related]
18. Alterations in the hematological profile in rat following whole body gamma radiation with and without venoruton pretreatment. Kanwar KC; Verma A J Environ Pathol Toxicol Oncol; 1992; 11(4):235-9. PubMed ID: 1507075 [TBL] [Abstract][Full Text] [Related]
19. [Anti-edema activity of injectable Venoruton in abdominal surgery]. De Anna D; Liboni A; Paoli M; Pollinzi V; Malin L; Mannella P; Ambroso G; Oberhauser V Minerva Chir; 1979 Oct; 34(20):1377-92. PubMed ID: 503345 [TBL] [Abstract][Full Text] [Related]
20. Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat. Dobyan DC; Bull JM; Strebel FR; Sunderland BA; Bulger RE Lab Invest; 1986 Nov; 55(5):557-63. PubMed ID: 3773477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]